SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-100790
Filing Date
2024-04-18
Accepted
2024-04-18 16:12:04
Documents
15
Period of Report
2024-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d786433d8k.htm   iXBRL 8-K 33040
2 EX-3.1 d786433dex31.htm EX-3.1 74106
3 EX-10.1 d786433dex101.htm EX-10.1 42748
  Complete submission text file 0001193125-24-100790.txt   304625

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20240412.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20240412_lab.xml EX-101.LAB 17981
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20240412_pre.xml EX-101.PRE 11269
18 EXTRACTED XBRL INSTANCE DOCUMENT d786433d8k_htm.xml XML 3705
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 24854424
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)